HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
Tekla Life Sciences Investors (HQL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 48 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 0.0 | 22 | 0.0 | 1.9 | 30 | 2.1 | 2.1 | 1.9 | 18 | 12 | 48 | |
| 2.9 | – | 2.6 | – | 2.7 | 2.6 | 2.5 | 2.5 | 2.8 | 2.5 | 2.4 | 3.1 | |
| 7.3 | 0.0 | 19 | 0.0 | 1.9 | 27 | 2.1 | 2.1 | 1.9 | 16 | 9.2 | 45 | |
| 0.0 | 0.0 | 1.4 | 0.0 | 2.9 | 2.0 | 2.7 | 2.7 | 3.2 | 2.7 | 0.7 | 3.3 | |
| 0.0 | 0.0 | 15 | 0.0 | 2.9 | 38 | 2.7 | 2.7 | 3.2 | 63 | -124 | -20 | |
| -76 | 0.0 | -28 | 0.0 | -0.9 | -11 | -0.7 | -0.7 | -1.3 | -47 | 133 | 65 | |
| -76 | 0.0 | -28 | 0.0 | 34 | -11 | 50 | 50 | 35 | -47 | 133 | 65 | |
| 0.0 | -14 | -0.7 | 17 | 0.0 | 0.0 | 25 | -0.3 | – | – | – | – | |
| -76 | 0.0 | -28 | 0.0 | 34 | -11 | 50 | 50 | 35 | -47 | 133 | 65 | |
| -76 | 0.0 | -28 | 0.0 | 34 | -11 | 101 | 101 | 35 | -47 | 133 | 65 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.